Sequenom (SQNM)

Add to Watchlists
Create an Alert
2.50 -0.02  -0.79% NASDAQ Apr 15, 8:00PM BATS Real time Currency in USD
View Full Chart
SQNM Price Chart
View All Events

SQNM Events

Date Type Description
Feb 27 Misc Sequenom, Inc. Q4 2013 Earning Conference Call
Feb 27 Earnings Sequenom, Inc. Q4 2013 Earning Result. Estimate: -0.14.
Nov 07 Misc Sequenom, Inc. Q3 2013 Earning Conference Call
Nov 07 Earnings Sequenom, Inc. Q3 2013 Earning Result. Estimate: -0.24.
Jul 24 Misc Sequenom, Inc. Announces Date of Second Quarter 2013 Financial Results and Conference Call
Jul 24 Earnings Sequenom, Inc. Announces Date of Second Quarter 2013 Financial Results and Conference Call. Estimate: -0.23.
Jun 11 Misc AGM Event for Sequenom Inc
May 09 Misc Sequenom, Inc. Announces Date of First Quarter 2013 Financial Results and Conference Call
May 09 Earnings 1Q13 Earnings. Estimate: -0.26.
View All Performance Charts

SQNM Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sequenom is down 37.25% over the last year vs S&P 500 Total Return up 18.46%, Affymetrix up 76.42%, and Luminex up 0.60%.

Get Quote for

Pro Strategies Featuring SQNM

Did Sequenom make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.

SQNM Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Current Fiscal Year End: December 31, 2014
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Industry Code: 5417
  • NAICS Sector: Professional, Scientific, and Technical Services
  • NAICS Sector Code: 54

Sequenom, Inc. designs, develops, manufactures and markets innovative technology instrumentation. The company operates through two segments: Molecular Diagnostics and Genetic Analysis. The Molecular Diagnostics segment researches, develops and commercializes noninvasive molecular diagnostic tests for noninvasive womens' health-related and prenatal diagnostics, ophthalmology, oncology, infectious diseases, and other medical conditions disorders and diseases. The Genetic Analysis segment designs, markets and provides maintenance services for the proprietary MassARRAY system, comprised of hardware, software applications, consumable chips and reagents which are marketed to premier clinical research laboratories, bio-agriculture, bio-technology and pharmaceutical companies. The company was founded in 1994 and is headquartered in San Diego, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SQNM 2.50 -0.02 -0.79% 290.65M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.